A PepFect14 analog improves non-viral CRISPR delivery in primary human cells to facilitate genome editing and repair. [PDF]
du Rand A +8 more
europepmc +1 more source
Update on Approved Therapies for Dystrophic and Junctional Epidermolysis Bullosa. [PDF]
Pappalardo A +5 more
europepmc +1 more source
Novel COL7A1 Mutations of Hallopeau-Siemens Type Recessive Dystrophic Epidermolysis [PDF]
application/pdfDystrophic epidermolysis bullosa (DEB) is caused by mutations in the COL7A] gene encoding type VII collagen. DEB is clinically characterized by mucocutaneous blistering in response to minor trauma.
Murai, Takaya +5 more
core
From the Microscope to the Genome: A New Era in the Molecular Genetics of Epidermolysis Bullosa. [PDF]
Tsvetkova M, Dimitrova T, Yaneva G.
europepmc +1 more source
213 Epidermolysis bullosa acquisita in a patient with biallelic COL7A1 mutations [PDF]
L. Guerra +6 more
openaire +1 more source
Case Report: Successful treatment of dystrophic epidermolysis bullosa pruriginosa with upadacitinib in a patient with <i>COL7A1</i>, <i>CARD14</i>, and <i>G6PD</i> gene mutations. [PDF]
Li H +5 more
europepmc +1 more source
Neonatal Skin Blistering and Denudement Caused by Epidermolysis Bullosa. [PDF]
Folkert G, Aggarwal A, Douvoyiannis M.
europepmc +1 more source
Revisiting Type VII Collagen Mislocalisation in Dystrophic Epidermolysis Bullosa Using High-Resolution Imaging. [PDF]
Watanabe M +4 more
europepmc +1 more source
Epidermolysis bullosa acquisita in a patient with biallelic COL7A1 mutations [PDF]
openaire +1 more source
Epidermolysis Bullosa Classification and Current Approach to Diagnosis. [PDF]
Mumber HE, Perman MJ.
europepmc +1 more source

